197 related articles for article (PubMed ID: 31347918)
1. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
Hsu CP; Oka S; Shao D; Hariharan N; Sadoshima J
Circ Res; 2009 Aug; 105(5):481-91. PubMed ID: 19661458
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-195 Regulates Metabolism in Failing Myocardium Via Alterations in Sirtuin 3 Expression and Mitochondrial Protein Acetylation.
Zhang X; Ji R; Liao X; Castillero E; Kennel PJ; Brunjes DL; Franz M; Möbius-Winkler S; Drosatos K; George I; Chen EI; Colombo PC; Schulze PC
Circulation; 2018 May; 137(19):2052-2067. PubMed ID: 29330215
[TBL] [Abstract][Full Text] [Related]
5. NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Xiong X; Yu J; Fan R; Zhang C; Xu L; Sun X; Huang Y; Wang Q; Ruan HB; Qian X
PLoS One; 2019; 14(2):e0212523. PubMed ID: 30794635
[TBL] [Abstract][Full Text] [Related]
6. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT.
Choi SE; Fu T; Seok S; Kim DH; Yu E; Lee KW; Kang Y; Li X; Kemper B; Kemper JK
Aging Cell; 2013 Dec; 12(6):1062-72. PubMed ID: 23834033
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD(+) protects the heart against pressure overload.
Yano M; Akazawa H; Oka T; Yabumoto C; Kudo-Sakamoto Y; Kamo T; Shimizu Y; Yagi H; Naito AT; Lee JK; Suzuki J; Sakata Y; Komuro I
Sci Rep; 2015 Nov; 5():15857. PubMed ID: 26522369
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
9. Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors.
Wang P; Du H; Zhou CC; Song J; Liu X; Cao X; Mehta JL; Shi Y; Su DF; Miao CY
Cardiovasc Res; 2014 Dec; 104(3):477-88. PubMed ID: 25341895
[TBL] [Abstract][Full Text] [Related]
10. Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.
Collier JB; Schnellmann RG
Cell Mol Life Sci; 2020 Sep; 77(18):3643-3655. PubMed ID: 31873757
[TBL] [Abstract][Full Text] [Related]
11. Perturbations of NAD
Agerholm M; Dall M; Jensen BAH; Prats C; Madsen S; Basse AL; Graae AS; Risis S; Goldenbaum J; Quistorff B; Larsen S; Vienberg SG; Treebak JT
Am J Physiol Endocrinol Metab; 2018 Apr; 314(4):E377-E395. PubMed ID: 29208611
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase.
Higgins CB; Mayer AL; Zhang Y; Franczyk M; Ballentine S; Yoshino J; DeBosch BJ
Nat Commun; 2022 Feb; 13(1):1074. PubMed ID: 35228549
[TBL] [Abstract][Full Text] [Related]
13. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters.
Zhang T; Berrocal JG; Frizzell KM; Gamble MJ; DuMond ME; Krishnakumar R; Yang T; Sauve AA; Kraus WL
J Biol Chem; 2009 Jul; 284(30):20408-17. PubMed ID: 19478080
[TBL] [Abstract][Full Text] [Related]
14. NAMPT/SIRT1 Attenuate Ang II-Induced Vascular Remodeling and Vulnerability to Hypertension by Inhibiting the ROS/MAPK Pathway.
Zhou L; Zhang S; Bolor-Erdene E; Wang L; Tian D; Mei Y
Oxid Med Cell Longev; 2020; 2020():1974265. PubMed ID: 33488923
[TBL] [Abstract][Full Text] [Related]
15. Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy.
Oka SI; Byun J; Huang CY; Imai N; Ralda G; Zhai P; Xu X; Kashyap S; Warren JS; Alan Maschek J; Tippetts TS; Tong M; Venkatesh S; Ikeda Y; Mizushima W; Kashihara T; Sadoshima J
Circ Res; 2021 Jun; 129(1):114-130. PubMed ID: 33928788
[TBL] [Abstract][Full Text] [Related]
16. Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
Zhao Y; Guan YF; Zhou XM; Li GQ; Li ZY; Zhou CC; Wang P; Miao CY
Stroke; 2015 Jul; 46(7):1966-74. PubMed ID: 26060246
[TBL] [Abstract][Full Text] [Related]
17. Restoring NAD
Katayoshi T; Nakajo T; Tsuji-Naito K
J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy.
Diguet N; Trammell SAJ; Tannous C; Deloux R; Piquereau J; Mougenot N; Gouge A; Gressette M; Manoury B; Blanc J; Breton M; Decaux JF; Lavery GG; Baczkó I; Zoll J; Garnier A; Li Z; Brenner C; Mericskay M
Circulation; 2018 May; 137(21):2256-2273. PubMed ID: 29217642
[TBL] [Abstract][Full Text] [Related]
19. NAMPT-mediated NAD
Nielsen KN; Peics J; Ma T; Karavaeva I; Dall M; Chubanava S; Basse AL; Dmytriyeva O; Treebak JT; Gerhart-Hines Z
Mol Metab; 2018 May; 11():178-188. PubMed ID: 29551635
[TBL] [Abstract][Full Text] [Related]
20.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
[Next] [New Search]
